Synthesis and biological evaluation of cytotoxic properties of stilbene-based resveratrol analogs

European Journal of Medicinal Chemistry

Volumn 44, Issue 2, 2009, Pages 701-707

  de Lima, Dênis Pires ^a   Rotta, Rodrigo ^a   Beatriz, Adilson ^a   Marques, Maria Rita ^a   Montenegro, Raquel C ^b   Vasconcellos, Marne C ^b   Pessoa, Cláudia ^b   de Moraes, Manoel O ^b   Costa Lotufo, Letícia V ^b   Frankland Sawaya, Alexandra Christine Helena ^c   Eberlin, Marcos Nogueira ^c  

^a FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cytotoxic properties; Embryonic development; Resveratrol analogs; Stilbenes

Indexed keywords

1 (3,4 DIMETHOXYPHENYL) 2 PHENYL ETHENE; 3 (2 HYDROXYPHENYL) 2 PHENYLACRYLIC ACID; 3 (3,4 DIMETHOXYPHENYL) 2 PHENYLACRYLIC ACID; 3 (4 ACETOXY 3 METHOXYPHENYL) 2 PHENYLACRYLIC ACID; 3 (4 HYDROXY 3 METHOXYPHENYL) 2 PHENYLACRYLIC ACID; 3 (4 METHOXYPHENYL) 2 PHENYLACRYLIC ACID; CASPASE 9; COMBRETASTATIN A4; CYCLIN D1; DOXOLEM; DOXORUBICIN; RESVERATROL; RESVERATROL DERIVATIVE; STAT3 PROTEIN; STILBENE; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARBON NUCLEAR MAGNETIC RESONANCE; CELL CYCLE ARREST; CELL STRAIN HCT 8; CELL STRAIN HL 60; CELL STRAIN K 562; CELL STRAIN MCF 7; CHEMICAL REACTION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; EMBRYO DEVELOPMENT; HEMOLYSIS; HUMAN; HUMAN CELL; IC 50; MDA MB 435 CELL; MELANOMA B16; MEMBRANE DAMAGE; MITOSIS INHIBITION; MOUSE; NONHUMAN; OOCYTE DEVELOPMENT; PC 3 CELL; PERKIN REACTION; PROTEIN PHOSPHORYLATION; SEA URCHIN; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; EMBRYONIC DEVELOPMENT; ERYTHROCYTES; HEMOLYSIS; HUMANS; INHIBITORY CONCENTRATION 50; MICE; OVUM; SEA URCHINS; STILBENES;

EID: 60149101730     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2008.05.003     Document Type: Article

References (36)

1. Simoni D., Roberti M., Invidiata F.P., Aiello E., Aiello S., Marchetti P., Baruchello R., Eleopra M., Di Cristina A., Grimaudo S., Gebbia N., Crosta L., Dieli F., and Tolomeo M. Bioorg. Med. Chem. Lett. 16 (2006) 3245-3248
2. Griggs J., Metcalfe J.C., and Hesketh R. Lancet Oncol. 2 (2001) 82-87
3. Mokni M., Elkahoui S., Limam F., Amri M., and Aouani E. Neurochem. Res. 32 (2007) 981-987
4. Cirla A., and Mann J. Nat. Prod. Rep. 20 (2003) 558-564
5. Pettit G.R., Rhodes M.R., Herald D.L., Hamel E., Schmidt J.M., and Pettit R.K. J. Med. Chem. 48 (2005) 4087-4099
6. Latruffe N., Delmas D., Jannin B., Cherkaoui Malki M., Passilly-Degrace P., and Berlot J.P. Int. J. Mol. Med. 10 (2002) 755-760
7. Bhat K.P., and Pezzuto J.M. Cancer Res. 61 (2001) 6137-6144
8. Ciolino H.P., and Yeh G.C. Adv. Exp. Med. Biol. 492 (2001) 183-193
9. Kang J.H., Park Y.H., Choi S.W., Yang E.K., and Lee W.J. Exp. Mol. Med. 35 (2003) 467-474
10. Solladié G., Pasturel-Jacopé Y., and Maignan J. Tetrahedron 59 (2003) 3315-3321
11. Kelley C.J., Mahajan J.R., Brooks L.C., Neubert L.A., Breneman W.R., and Carmack M. J. Org. Chem. 40 (1975) 1804-1815
12. Kelley C.J., Harruff R.C., and Carmack M. J. Org. Chem. 41 (1976) 449-455
13. Bartok M., Wittmann G., Gondos G., and Smith G.V. J. Org. Chem. 52 (1987) 1139-1141
14. Sugimura T., Watanabe J., Okuyama T., and Nitta Y. Tetrahedron: Asymmetry 16 (2005) 1573-1575
15. Majima T., Tojo S., Ishida A., and Takamuku S. J. Org. Chem. 61 (1996) 7793-7800
16. Roberts J.C., and Pincock J.A. J. Org. Chem. 69 (2004) 4279-4282
17. Roberts J.C., and Pincock J.A. J. Org. Chem. 71 (2006) 1480-1492
18. Heynekamp J.J., Weber W.M., Hunsaker L.A., Gonzales A.M., Orlando R.A., Deck L.M., and Jagt D.L.V. J. Med. Chem. 49 (2006) 7182-7189
19. Liu J., Zhao Y., Zhou Y., Li L., Zhang T.Y., and Zhang H. Org. Biomol. Chem. 1 (2003) 3227-3231
20. Kumar V., Sharma A., Sharma A., and Sinha A.K. Tetrahedron 63 (2007) 7640-7646
21. Dorrie J., Gerauer H., Wachter Y., and Zunino S.J. Cancer Res. 61 (2001) 4731-4739
22. Z. Ma, O. Molavi, A. Haddadi, R. Lai, R.A. Gossage, A. Lavasanifar, Cancer. Chemother. Pharmacol., in press. doi:10.1007/s00280-008-0704-z,
23. Murias M., Jager W., Handler N., Erker T., Horvath Z., Szekeres T., Nohl H., and Gille L. Biochem. Pharmacol. 69 (2005) 903-912
24. Cai Y.J., Fang J.G., Ma L.P., Yang L., and Liu Z.L. Biochim. Biophys. Acta 1637 (2003) 31-38
25. Gaukroger K., Hadfield J.A., Hepworth L.A., Lawrence N.J., and McGown A.T. J. Org. Chem. 66 (2001) 8135-8138
26. Jacobs R.S., and Wilson L. In: Aszalor A. (Ed). Modern Analysis of Antibiotics (1986), Marcel Dekker Inc., New York 481-493
27. Gross P.R., Malkin L.I., and Moyer W.A. Proc. Natl. Acad. Sci. U S A 51 (1964) 407-414
28. Brandhorst B.P. Development Biology: A Comprehensive Synthesis. In: Browder L.W. (Ed). Oogenesis (1985), Plenum, New York 525-576
29. Costa-Lotufo L.V., Jimenez P.C., Wilke D.V., Leal L.K., Cunha G.M., Silveira E.R., Canuto K.M., Viana G.S., Moraes M.E., de Moraes M.O., and Pessoa C. Z. Naturforsch. C 58 (2003) 675-680
30. Costa-Lotufo L.V., Khan M.T., Ather A., Wilke D.V., Jimenez P.C., Pessoa C., de Moraes M.E., and de Moraes M.O. J. Ethnopharmacol. 99 (2005) 21-30
31. Fusetani N. In: Scheuer P. (Ed). Bioorganic Marine Chemistry (1987), Springer Verlag, Berlin 61-91
32. Pagano G., de Biase A., Deeva I.B., Degan P., Doronin Y.K., Iaccarino M., Oral R., Trieff N.M., Warnau M., and Korkina L.G. Life Sci. 68 (2001) 1735-1749
33. Sharma P., and Sharma J.D. J. Ethnopharmacol. 74 (2001) 239-243
34. In: Perrin D.D., and Armarego W.L.F. (Eds). Purification of Laboratory Chemicals (1988), Pergamon Press, Oxford
35. Mosmann T. J. Immunol. Methods 65 (1983) 55-63
36. Jimenez P.C., Fortier S.C., Lotufo T.M.C., Pessoa C., Moraes M.E.A., de Moraes M.O., and Costa-Lotufo L.V. J. Exp. Mar. Biol. Ecol. 287 (2003) 93-101